• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-140-5p在骨肉瘤中表达下调,过表达微小RNA-140-5p可通过下调葡萄糖转运蛋白1(GLUT-1)抑制癌细胞增殖。

MicroRNA-140-5p is Downregulated in Osteosarcoma and Overexpression of MicroRNA-140-5p Inhibits Cancer Cell Proliferation by Downregulating GLUT-1.

作者信息

Geng Xiaoling, Wang Haoyu, Xu Lichen, Han Yazhou, Liu Yadong

机构信息

Department of Gastroenterology & Hepatology, First Affiliated Hospital of Dalian Medical University, Dalian, 116000, People's Republic of China.

Department of Orthopedics, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, Shanxi, People's Republic of China.

出版信息

Onco Targets Ther. 2021 Feb 11;14:995-1002. doi: 10.2147/OTT.S289229. eCollection 2021.

DOI:10.2147/OTT.S289229
PMID:33603404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884943/
Abstract

BACKGROUND

MicroRNA-140-5p plays pivotal role in different types of human malignancies, while its involvement in osteosarcoma is unknown.

OBJECTIVE

Our study aimed to investigate the functionality of microRNA-140-5p in osteosarcoma.

METHODS

Plasma levels of microRNA-140-5p and glucose transporter 1 (GLUT-1) in both osteosarcoma and healthy controls were measured by qRT-PCR and ELISA, respectively. Correlation between plasma levels of microRNA-140-5p and GLUT-1 was analyzed by Pearson correlation coefficient. Correlation between plasma levels of microRNA-140-5p and clinical data of patients with osteosarcoma was analyzed by Chi-square test. MicroRNA-140-5p mimic and GLUT-1 expression vector were transfected into cells of human osteosarcoma cell lines, and the effects on microRNA-140-5p expression, GLUT-1 expression and cell proliferation were analyzed by qRT-PCR, Western-blot and CCK-8 assay, respectively.

RESULTS

Plasma levels of microRNA-140-5p were significantly lower and plasma levels of GLUT-1 were significantly higher in osteosarcoma patients than that in healthy controls. Levels of plasma microRNA-140-5p and GLUT-1 were reversely correlated in osteosarcoma patients. Plasma levels of microRNA-140-5p were correlated with tumor size but not with other clinical data of patients. MicroRNA-140-5p mimic significantly inhibited cancer cell proliferation, while GLUT-1 overexpression significantly promoted cancer cell proliferation. MicroRNA-140-5p mimic significantly downregulated GLUT-1 expression.

CONCLUSION

GLUT-1 overexpression showed no significant effect on microRNA-140-5p expression but attenuated the inhibitory effects of microRNA-140-5p mimic on cell proliferation. We therefore conclude that microRNA-140-5p is downregulated in osteosarcoma and overexpression of microRNA-140-5p may inhibit cancer cell proliferation by downregulating GLUT-1.

摘要

背景

微小RNA - 140 - 5p在不同类型的人类恶性肿瘤中起关键作用,但其在骨肉瘤中的作用尚不清楚。

目的

本研究旨在探讨微小RNA - 140 - 5p在骨肉瘤中的功能。

方法

分别采用qRT - PCR和ELISA检测骨肉瘤患者及健康对照者血浆中微小RNA - 140 - 5p和葡萄糖转运蛋白1(GLUT - 1)的水平。采用Pearson相关系数分析血浆微小RNA - 140 - 5p水平与GLUT - 1水平之间的相关性。采用卡方检验分析血浆微小RNA - 140 - 5p水平与骨肉瘤患者临床资料之间的相关性。将微小RNA - 140 - 5p模拟物和GLUT - 1表达载体转染到人骨肉瘤细胞系细胞中,分别采用qRT - PCR、Western - blot和CCK - 8法分析对微小RNA - 140 - 5p表达、GLUT - 1表达和细胞增殖的影响。

结果

骨肉瘤患者血浆微小RNA - 140 - 5p水平显著低于健康对照者,血浆GLUT - 1水平显著高于健康对照者。骨肉瘤患者血浆微小RNA - 140 - 5p水平与GLUT - 1水平呈负相关。血浆微小RNA - 140 - 5p水平与肿瘤大小相关,但与患者的其他临床资料无关。微小RNA - 140 - 5p模拟物显著抑制癌细胞增殖,而GLUT - 1过表达显著促进癌细胞增殖。微小RNA - 140 - 5p模拟物显著下调GLUT - 1表达。

结论

GLUT - 1过表达对微小RNA - 140 - 5p表达无显著影响,但减弱了微小RNA - 140 - 5p模拟物对细胞增殖的抑制作用。因此,我们得出结论,微小RNA - 140 - 5p在骨肉瘤中表达下调,微小RNA - 140 - 5p过表达可能通过下调GLUT - 1抑制癌细胞增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/786d64c1650c/OTT-14-995-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/2be3fe5a61e3/OTT-14-995-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/d040993bdf66/OTT-14-995-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/38fa0755f14f/OTT-14-995-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/786d64c1650c/OTT-14-995-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/2be3fe5a61e3/OTT-14-995-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/d040993bdf66/OTT-14-995-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/38fa0755f14f/OTT-14-995-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/7884943/786d64c1650c/OTT-14-995-g0004.jpg

相似文献

1
MicroRNA-140-5p is Downregulated in Osteosarcoma and Overexpression of MicroRNA-140-5p Inhibits Cancer Cell Proliferation by Downregulating GLUT-1.微小RNA-140-5p在骨肉瘤中表达下调,过表达微小RNA-140-5p可通过下调葡萄糖转运蛋白1(GLUT-1)抑制癌细胞增殖。
Onco Targets Ther. 2021 Feb 11;14:995-1002. doi: 10.2147/OTT.S289229. eCollection 2021.
2
LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.长链非编码RNA SNHG16通过靶向微小RNA-146a-5p促进骨肉瘤细胞的增殖和迁移。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):96-104. doi: 10.26355/eurrev_201901_16753.
3
Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1.长链非编码RNA AWPPH的下调通过下调葡萄糖转运蛋白1(GLUT-1)来抑制结肠癌细胞增殖。
Oncol Lett. 2019 Aug;18(2):2007-2012. doi: 10.3892/ol.2019.10515. Epub 2019 Jun 21.
4
MicroRNA-150-5p inhibits proliferation and invasion of osteosarcoma cells by down-regulating VEGFA.miRNA-150-5p 通过下调 VEGFA 抑制骨肉瘤细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9265-9273. doi: 10.26355/eurrev_202009_23008.
5
MicroRNA-449b-5p Suppresses Proliferation, Migration, and Invasion of Osteosarcoma by Targeting c-Met.miR-449b-5p 通过靶向 c-Met 抑制骨肉瘤的增殖、迁移和侵袭。
Med Sci Monit. 2019 Aug 19;25:6236-6243. doi: 10.12659/MSM.918454.
6
MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.微小 RNA-493-5p 通过靶向 Kruppel 样因子 5 抑制骨肉瘤细胞的增殖和转移。
J Cell Physiol. 2019 Aug;234(8):13525-13533. doi: 10.1002/jcp.28030. Epub 2019 Feb 17.
7
MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.miR-337-5p 通过 ERBB、MAPK 和 VEGF 通路参与骨肉瘤的发生发展。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5460-5470. doi: 10.26355/eurrev_201809_15806.
8
MiRNA-1225 Inhibits Osteosarcoma Tumor Growth and Progression by Targeting YWHAZ.微小RNA-1225通过靶向14-3-3ζ抑制骨肉瘤肿瘤生长和进展。
Onco Targets Ther. 2021 Jan 6;14:15-27. doi: 10.2147/OTT.S282485. eCollection 2021.
9
MicroRNA-382-5p inhibits osteosarcoma development and progression by negatively regulating VEZF1 expression.微小RNA-382-5p通过负向调控VEZF1的表达来抑制骨肉瘤的发生和进展。
Oncol Lett. 2021 Nov;22(5):752. doi: 10.3892/ol.2021.13013. Epub 2021 Aug 27.
10
MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.微小 RNA-330-5p 通过调控 SPRY2 促进骨肉瘤的发展。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8761-8770. doi: 10.26355/eurrev_201910_19270.

引用本文的文献

1
Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies.骨肉瘤治疗的进展:克服化疗耐药性并探索新的药理学策略。
Pharmaceuticals (Basel). 2025 Apr 3;18(4):520. doi: 10.3390/ph18040520.
2
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma.葡萄糖代谢重编程:骨肉瘤进展中的代谢改变。
J Bone Oncol. 2024 Jan 4;44:100521. doi: 10.1016/j.jbo.2024.100521. eCollection 2024 Feb.
3
Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters.

本文引用的文献

1
miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.miRNA 谱分析确定了与骨肉瘤发生和转移时间相关的失调 miRNA,该分析基于两个大型队列。
Mol Oncol. 2018 Jan;12(1):114-131. doi: 10.1002/1878-0261.12154. Epub 2017 Dec 1.
2
Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells.Mir-150上调骨肉瘤细胞中的Glut1并增加糖酵解
Asian Pac J Cancer Prev. 2017 Apr 1;18(4):1127-1131. doi: 10.22034/APJCP.2017.18.4.1127.
3
Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression.
鞘氨醇激酶-1在骨肉瘤中过表达并与缺氧相关:与临床病理参数的关系
Cancers (Basel). 2022 Jan 19;14(3):499. doi: 10.3390/cancers14030499.
下调微小RNA-144通过调节葡萄糖转运蛋白1(GLUT1)的表达介导肺癌细胞的代谢转变。
Oncol Lett. 2016 Jun;11(6):3772-3776. doi: 10.3892/ol.2016.4468. Epub 2016 Apr 19.
4
Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.热敏水凝胶对阿霉素、顺铂和甲氨蝶呤的局部共递送用于增强骨肉瘤治疗
ACS Appl Mater Interfaces. 2015 Dec 16;7(49):27040-8. doi: 10.1021/acsami.5b09112. Epub 2015 Dec 1.
5
MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA.微小RNA-140-5p通过靶向血管内皮生长因子A抑制结直肠癌的进展。
Cell Physiol Biochem. 2015;37(3):1123-33. doi: 10.1159/000430237. Epub 2015 Sep 25.
6
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.骨肉瘤:当前治疗方法与成功的协作途径
J Clin Oncol. 2015 Sep 20;33(27):3029-35. doi: 10.1200/JCO.2014.59.4895. Epub 2015 Aug 24.
7
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.卤夫酮在骨肉瘤临床前模型中的抗癌活性:抑制肿瘤生长和肺转移。
Oncotarget. 2015 Jun 10;6(16):14413-27. doi: 10.18632/oncotarget.3891.
8
ROS and energy metabolism in cancer cells: alliance for fast growth.癌细胞中的活性氧和能量代谢:快速生长的联盟
Arch Pharm Res. 2015 Mar;38(3):338-45. doi: 10.1007/s12272-015-0550-6. Epub 2015 Jan 20.
9
PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.载 PLK1shRNA 和阿霉素的热敏性 PLGA-PEG-PLGA 水凝胶用于骨肉瘤治疗。
Biomaterials. 2014 Oct;35(30):8723-34. doi: 10.1016/j.biomaterials.2014.06.045. Epub 2014 Jul 10.
10
Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment.通过药物再利用克服药物开发瓶颈:将双胍类药物重新用于靶向能量代谢以治疗癌症
Nat Med. 2014 Jun;20(6):591-3. doi: 10.1038/nm.3596.